ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 747856 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 747856; 2) Community: the network communities that were significantly associated with the response to NSC 747856; 3) Molecule: the relationships between components within communities and NSC 747856; 4) MDR: the compounds that were significantly associated with the NSC 747856.

NSC Compound Enrichment Correlation
NSC 662123 Null 0.0382675857669588 0.18131682
NSC 667903 Null 0.0382675857669588 0.22433995
NSC 679795 Null 0.0382675857669588 0.022671284
NSC 681635 Camptothecin Derivative 0.0382675857669588 0.12701417
NSC 681639 Camptothecin Derivative 0.0382675857669588 0.10727533
NSC 687453 2-Propenoic acid, 3-[2,3-dihydro-2-(4-hydroxy- 3-methoxyphenyl)-7-methoxy-3-(methoxycarbonyl)- 5-benzofuranyl]-, methyl ester, racemic mixture of NSC 674908 and NSC 674996 0.0382675857669588 0.065855505
NSC 692641 Null 0.0382675857669588 -0.33540211
NSC 693773 Null 0.0382675857669588 0.19150603
NSC 694000 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester 0.0382675857669588 -0.16802937
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0382675857669588 -0.15565567
Total:45  Current:33    [First] [Prev] [Next] [Last]